Logo Prima Biomed

Welcome to the Newsroom

30 June 2017

Prima BioMed Announces Pricing of US$5.0 Million Registered Direct Offering of Its American Depositary Shares


SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima” or the “Company”) today announced it has entered into a securities purchase agreement with certain accredited investors to purchase 2,631,268 of its American Depositary Shares (“ADSs”) at a purchase price per ADS of US$1.90 in a registered direct offering, for total gross proceeds of approximately US$5.0 million (equivalent to approximately AU$6.5 million).